The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping
Open accessAbstract
Breast cancer cell lines have been widely used for breast cancer modelling which encompasses a panel of diseases with distinct phenotypical associations. Though cell lines provide unlimited homogenous materials for tumor studies and are relatively easy to culture, they are known to accumulate mutations duringthe initial establishment and subsequent series of cultivations. Thus, whether breast cancer cell line heterogeneity reflects that of carcinoma remains an important issue to resolve before drawing any reliable conclusion at the tumor level using cell lines. Inconsistent nomenclatures used for breast cancer cell line subtyping and the different number of subtypes grouped for cell lines and tumors make their direct matching elusive. By analyzing the molecular features of 92 breast cancer cell lines as documented by different literatures, we categorize 84 cell lines into 5 groups to be consistent with breast tumor classification. After combing through these cell lines, we summarized the molecular features, genetically and epigenetically, of each subtype, and manually documented 10 cell lines lacking explicit information on subtyping. Nine cell lines, either found inconsistent on their primary molecular features from different studies or being contaminated at the origin, are not suggested as the first choice for experimental use. We conclude that breast tumor cell lines, though having a high mutational frequency with many uncertainties and could not fully capture breast cancer heterogeneity, are feasible but crude models for tumors of the same subtype. New cell lines with enriched interferon regulated genes need to be established to enlarge the coverage of cell lines on tumor heterogeneity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Lehmann, B. D., Bauer, J. A., Chen, X., Sanders, M. E., Chakravarthy, A. B., Shyr, Y., & Pietenpol, J. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45014 · Cited by 5,592
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppe, J.-P., Tong, F., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,188
Hallmarks of 'BRCAness' in sporadic cancers
Turner, N., Tutt, A., & Ashworth, A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1457 · Cited by 1,657
Cheang, M. C. U., Voduc, D., Bajdik, C., Leung, S., McKinney, S., Chia, S. K., Perou, C. M., & Nielsen, T. O. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1658 · Cited by 1,195
Kenny, P. A., Lee, G. Y., Myers, C. A., Neve, R. M., Semeiks, J. R., Spellman, P. T., Lorenz, K., Lee, E. H., Barcellos‐Hoff, M. H., PETERSEN, O. W., et al. (2008) · eScholarship (California Digital Library) · Cited by 1,039
Breast Cancer Research and Treatment
Alexander, M. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006151427889 · Cited by 997
Breast cancer intrinsic subtype classification, clinical use and future trends.
Dai, X., Li, T., Bai, Z., Yang, Y., Liu, X., Zhan, J., & Shi, B. (2015) · Europe PMC (PubMed Central) · Cited by 921
Self-citationKao, J., Salari, K., Bocanegra, M., Choi, Y.-L., Girard, L., Gandhi, J., Kwei, K. A., Hernandez-Boussard, T., Wang, P., Gazdar, A. F., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006146 · Cited by 788
Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update
Lacroix, M., & Leclercq, G. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000014042.54925.cc · Cited by 782
Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization
Cailleau, R., Olivé, M., & Cruciger, Q. V. J. (1978) · In Vitro · doi:10.1007/bf02616120 · Cited by 679
Gene expression profiling of breast cell lines identifies potential new basal markers
Charafe-Jauffret, E., Ginestier, C., Monville, F., Finetti, P., Adélaïde, J., Cervera, N., Fekairi, S., Xerri, L., Jacquemier, J., Birnbaum, D., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209254 · Cited by 569
DNA methylation and breast carcinogenesis
Widschwendter, M., & Jones, P. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205606 · Cited by 457
Wang, B., & Elledge, S. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710061104 · Cited by 445
Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes
Dai, X., Xiang, L., Li, T., & Bai, Z. (2016) · Journal of Cancer · doi:10.7150/jca.13141 · Cited by 440
Self-citationHuman breast carcinoma cells in continuous culture: a review.
Engel, L. W., & Young, N. A. (1978) · PubMed · Cited by 345
Gazdar, A. F., Kurvari, V., Virmani, A., Gollahon, L., Sakaguchi, M., Westerfield, M., Kodagoda, D., Stasny, V., Cunningham, H. T., Wistuba, I. I., et al. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19981209)78:6<766::aid-ijc15>3.0.co;2-l · Cited by 341
BRCA1 Mutation Analysis of 41 Human Breast Cancer Cell Lines Reveals Three New Deleterious Mutants
Elstrodt, F., Hollestelle, A., Nagel, J. H. A., Gorin, M., Wasielewski, M., van den Ouweland, A., Merajver, S. D., Ethier, S. P., & Schutte, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2853 · Cited by 305
Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines
Hollestelle, A., Nagel, J. H. A., Smid, M., Lam, S., Elstrodt, F., Wasielewski, M., Ng, S. S., French, P. J., Peeters, J. K., Rozendaal, M. J., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0460-8 · Cited by 301
High EGFR gene copy number predicts poor outcome in triple-negative breast cancer
Park, H. S., Jang, M. H., Kim, E. J., Kim, H. J., Lee, H. J., Kim, Y. J., Kim, J. H., Kang, E., Kim, S.-W., Kim, I. A., et al. (2014) · Modern Pathology · doi:10.1038/modpathol.2013.251 · Cited by 300
Forozan, F., Mahlamäki, E., Monni, O. M., Chen, Y., Veldman, R., Jiang, Y. Y., Gooden, G. C., Ethier, S. P., Kallioniemi, A. H., & Kallioniemi, O. (2000) · PubMed · Cited by 278
Cultivation of Human Breast Carcinomas 2
(1958) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/21.6.1131 · Cited by 276
A resource for cell line authentication, annotation and quality control
Yu, M., Selvaraj, S. K., Liang-Chu, M. M. Y., Aghajani, S., Busse, M., Yuan, J., Lee, G., Peale, F., Klijn, C., Bourgon, R., et al. (2015) · Nature · doi:10.1038/nature14397 · Cited by 225 · cited 1×
“It is until recently that standardization on cell line nomenclature has been proposed [17], which helps regularize the naming of newly established cell lines and ultimately improvement in cell line annotation and scientific reproducibility [18].”
BackgroundMolecular cytogenetic analysis of 11 new breast cancer cell lines
Forozan, F., Veldman, R., Ammerman, C. A., Parsa, N. Z., Kallioniemi, A., Kallioniemi, O.-P., & Ethier, S. P. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6695007 · Cited by 219
Riaz, M., van Jaarsveld, M. T., Hollestelle, A., Prager-van der Smissen, W. J., Heine, A. A., Boersma, A. W., Liu, J., Helmijr, J., Ozturk, B., Smid, M., et al. (2013) · Breast Cancer Research · doi:10.1186/bcr3415 · Cited by 218
Kurebayashi, J., Otsuki, T., Tang, C. K., Kurosumi, M., Yamamoto, S., Tanaka, K., Mochizuki, M., Nakamura, H., & Soono, H. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690114 · Cited by 196
Ethier, S. P., Mahacek, M. L., Gullick, W. J., Frank, T. S., & Weber, B. L. (1993) · PubMed · Cited by 176
Tumor progression in four mammary epithelial cell lines derived from the same patient.
Band, V., Zajchowski, D. A., Swisshelm, K. L., Trask, D. K., Kulesa, V., Cohen, C., Connolly, J. L., & Sager, R. (1990) · PubMed · Cited by 176
Further evidence to support the melanocytic origin of MDA-MB-435
Ellison, G. (2002) · Molecular Pathology · doi:10.1136/mp.55.5.294 · Cited by 164
Targeting EGFR in Triple Negative Breast Cancer
Ueno, N. T., & Zhang, D. (2011) · Journal of Cancer · doi:10.7150/jca.2.324 · Cited by 161
A Human Breast Cell Model of Preinvasive to Invasive Transition
Rizki, A., Weaver, V. M., Lee, S.-Y., Rozenberg, G. I., Chin, K., Myers, C. A., Bascom, J. L., Mott, J. D., Semeiks, J. R., Grate, L. R., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2225 · Cited by 161
Comparison of features of human breast cancer cell lines and their corresponding tumors.
Wistuba, I. I., Behrens, C., Milchgrub, S., Syed, S., Ahmadian, M., Virmani, A. K., Kurvari, V., Cunningham, T. H., Ashfaq, R., Minna, J. D., et al. (1998) · PubMed · Cited by 147
Zheng, A., Kallio, A., & Härkönen, P. L. (2007) · Endocrinology · doi:10.1210/en.2006-1269 · Cited by 146
Identification and validation of an ERBB2 gene expression signature in breast cancers
Bertucci, F., Borie, N., Ginestier, C., Groulet, A., Charafe‐Jauffret, E., Adélaı̈de, J., Geneix, J., Bachelart, L., Finetti, P., Koki, A. T., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207361 · Cited by 140
Arun, B., Akar, U., Gutierrez‐Barrera, A. M., Hortobágyi, G. N., & Özpolat, B. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3003 · Cited by 119
Bacus, S. S., Kiguchi, K., Chin, D., King, C. R., & Huberman, E. (1990) · Molecular Carcinogenesis · doi:10.1002/mc.2940030607 · Cited by 116
Gioanni, J., François, D. L., Zanghellini, E., Mazeau, C., Ettore, F., Lambert, J. C., Schneider, M., & Dutrillaux, B. (1990) · British Journal of Cancer · doi:10.1038/bjc.1990.219 · Cited by 91
Larramendy, M. L., Lushnikova, T., Björkqvist, A., Wistuba, I. I., Virmani, A. K., Shivapurkar, N., Gazdar, A. F., & Knuutila, S. (2000) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(99)00226-5 · Cited by 77
Androgen sensitivity of the new human breast cancer cell line MFM-223.
Hackenberg, R., Lüttchens, S., Hofmann, J., Kunzmann, R., Hölzel, F., & Schulz, K.-D. (1991) · PubMed · Cited by 76
Hiscox, S., Baruah, B. P., Smith, C. R., Bellerby, R., Goddard, L., Jordan, N., Poghosyan, Z. P., Nicholson, R. I., Barrett-Lee, P. J., & Gee, J. M. W. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-458 · Cited by 70
Kurebayashi, J., Kurosumi, M., & Sonoo, H. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.163 · Cited by 64
Katchman, B. A., Ocal, I. T., Cunliffe, H. E., Chang, Y.-H. H., Hostetter, G. H., Watanabe, A. T., Lobello, J. R., & Lake, D. F. (2013) · Breast Cancer Research · doi:10.1186/bcr3407 · Cited by 62
Rye, P. D., Norum, L. F., Olsen, D. R., Garman-Vik, S., Kaul, S., & Fodstad, Ø. (1996) · International Journal of Cancer · Cited by 57
Meltzer, P. S., Leibovitz, A., Dalton, W., et al. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.164 · Cited by 54
Constitutive activation of pp125fak in newly isolated human breast cancer cell lines
Ignatoski, K. M. W., & Ethier, S. P. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006135331912 · Cited by 50
Gong, C., Fujino, K., Monteiro, L. J., Gomes, A., Drost, R., Davidson‐Smith, H., Takeda, S., Khoo, U., Jonkers, J., Sproul, D., et al. (2014) · Oncogene · doi:10.1038/onc.2014.421 · Cited by 48
Establishment and characterization of a new cell line from primary human breast carcinoma
Amadori, D., Bertoni, L., Flamigni, A., Savini, S., Giovanni, C. D., Casanova, S., Paola, F. D., Amadori, A., Giulotto, E., & Zoli, W. (1993) · Breast Cancer Research and Treatment · doi:10.1007/bf00666586 · Cited by 45
Fang, W. B., Yao, M., Jokar, I., Alhakamy, N. A., Berkland, C. J., Chen, J., Brantley‐Sieders, D. M., & Cheng, N. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3324-4 · Cited by 41
Lacroix, M., Haibe‐Kains, B., Hennuy, B., Laes, J., Lallemand, F., Gonze, I., Cardoso, F., Piccart, M. J., Leclercq, G., & Sotiriou, C. (2004) · Oncology Reports · doi:10.3892/or.12.4.701 · Cited by 36
Li, X., Liu, M., Zhang, Y., Wang, J., Zheng, Y., Li, J., Ma, B., & Song, X. (2010) · Medical Oncology · doi:10.1007/s12032-010-9742-6 · Cited by 35
Self-citationDvořánková, B., Szabó, P., Lacina, L., Kodet, O., Matoušková, E., & Smetana, K. (2012) · Histochemistry and Cell Biology · doi:10.1007/s00418-012-0918-3 · Cited by 29
Kim, Y., Kim, J., Lee, H. D., Jeong, J., Lee, W., & Lee, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079014 · Cited by 28
An in vitro Model of Human Breast Carcinogenesis: Epigenetic Aspects
Briand, P., & Lykkesfeldt, A. E. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1006434503061 · Cited by 26
Do Breast Cancer Cell Lines Provide a Relevant Model of the Patient Tumor Methylome?
Cope, L., Fackler, M. J., Bujanda, Z. A. L., Wolff, A. C., Visvanathan, K., Gray, J. W., Sukumar, S. V., & Umbricht, C. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105545 · Cited by 26
Illuminating luminal B: QSOX1 as a subtype-specific biomarker
Das, P., Siegers, G. M., & Postovit, L.-M. M. (2013) · Breast Cancer Research · doi:10.1186/bcr3417 · Cited by 18
Iuliis, F. D., Salerno, G., Giuffrida, A., Milana, B., Taglieri, L., Rubinacci, G., Giantulli, S., Terella, F., Silvestri, I., & Scarpa, S. (2015) · Tumor Biology · doi:10.1007/s13277-015-4075-x · Cited by 12
Cited by
Long noncoding RNA MALAT1 suppresses breast cancer metastasis
Kim, J., Piao, H.-L., Kim, B.-J., Yao, F., Han, Z., Wang, Y., Xiao, Z., Siverly, A. N., Lawhon, S. E., Ton, B. N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0252-3 · Cited by 771
The Regulatory Role of MicroRNAs in Breast Cancer
Loh, H.-Y., Norman, B. P., Lai, K.-S., Rahman, N. M. A. N. A., Alitheen, N. B. M., & Osman, M. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194940 · Cited by 326
mRNA Delivery for Therapeutic Anti-HER2 Antibody Expression In Vivo
Rybakova, Y., Kowalski, P. S., Huang, Y., Gonzalez, J. T., Heartlein, M. W., DeRosa, F., Delcassian, D., & Anderson, D. G. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.05.012 · Cited by 218
Chitosan-Based Nanoparticles of Targeted Drug Delivery System in Breast Cancer Treatment
Herdiana, Y., Wathoni, N., Shamsuddin, S., Joni, I. M., & Muchtaridi, M. (2021) · Polymers · doi:10.3390/polym13111717 · Cited by 196
Challenges and Perspectives in the Treatment of Diabetes Associated Breast Cancer
Samuel, S. M., Varghese, E., Varghese, S., & Büsselberg, D. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.08.004 · Cited by 141
Metadata
- Authors
- Dai, X., Cheng, H., Bai, Z., & Li, J.
- Venue
- Journal of Cancer
- Publisher
- Ivyspring International Publisher
- Published
- 2017
- Volume
- 8
- Issue
- 16
- Pages
- 3131-3141
- ISSN
- 1837-9664 (ISSN-L)
- OpenAlex
- W2756562465
- Cited by
- 1,100
- References
- 57
- FWCI
- 18.99
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.